Tomohiro Ota

Goldman Sachs Japan Co., Ltd. (GSJCL) is the Japan-based broker-dealer subsidiary of Goldman Sachs (Japan) Ltd., ultimately held by The Goldman Sachs Group, Inc. (NYSE: GS) in the US. The firm originated in 1974 and was formally founded in 1983. Headquartered in Tokyo, GSJCL offers Internet-based transaction services covering equity, debt, commodities and derivatives to a substantial and diversified client base, which includes corporations, financial institutions, governments and high net worth individuals.

AI Medical Service, Inc. engages in the development of artificial intelligence (AI) for diagnostic imaging of endoscope. The company was founded by Tomohiro Ota and Yoshiyuki Yamauchi on September 1, 2017 and is headquartered in Tokyo, Japan.